Literature DB >> 20622635

Pain management of musculoskeletal injuries in children: current state and future directions.

Samina Ali1, Amy L Drendel, Janeva Kircher, Suzanne Beno.   

Abstract

BACKGROUND: Pain is the most common reason for seeking health care in the Western world and is a contributing factor in up to 80% of all emergency department (ED) visits. In the pediatric emergency setting, musculoskeletal injuries are one of the most common painful presentations. Inadequate pain management during medical care, especially among very young children, can have numerous detrimental effects. No standard of care exists for the management of acute musculoskeletal injury-related pain in children. Within the ED setting, pain from such injuries has been repeatedly shown to be undertreated.
OBJECTIVES: Upon completion of this CME article, the reader should be better able to (1) distinguish multiple nonpharmacological techniques for minimizing and treating pain and anxiety in children with musculoskeletal injuries, (2) apply recent medical literature in deciding pharmacological strategies for the treatment of children with musculoskeletal injuries, and (3) interpret the basic principles of pharmacogenomics and how they relate to analgesic efficacy.
RESULTS: Pediatric musculoskeletal injuries are both common and painful. There is growing evidence that, in addition to pharmacological therapy, nonpharmacological methods can be introduced to improve analgesia in the ED and after discharge. Traditionally, acetaminophen with codeine has been used to treat moderate orthopedic injury-related pain in children. Other oral opioids (hydrocodone, oxycodone) are gaining popularity, as well. Current data suggest that ibuprofen is at least as effective as acetaminophen-codeine and codeine alone. Medication compliance might be improved if adverse effects were minimized, and ibuprofen has been shown to have a similar or better adverse effect profile than the oral opioids to which it has been compared. Pharmacogenomic data show that nearly 50% of individuals have at least 1 reduced functioning allele resulting in suboptimal conversion of codeine to active analgesic, so it is not surprising that codeine analgesic efficacy is not optimal. At the same time, nonpharmacological therapies are emerging as commonly used treatment options by parents and adjuncts to analgesic medication. The efficacy and role of techniques (massage, music therapy, transcutaneous electrical nerve stimulation), although promising, require further clarification in the treatment of orthopedic injury pain.
CONCLUSIONS: There is a need to optimize the measurement, documentation, and treatment of pain in children. There is growing evidence that nonpharmacological methods can be introduced to improve analgesia in the ED, and efforts to help parents implement these methods at home might be advantageous to optimize outpatient treatment plans. In pharmacotherapy, ibuprofen has emerged as an appropriate first-line choice for mild-moderate orthopedic pain. Other oral opioids (hydrocodone, oxycodone) are gaining popularity over codeine, because of the current understanding of the pharmacogenomics of such medications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622635     DOI: 10.1097/PEC.0b013e3181e5c02b

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  20 in total

Review 1.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

2.  Treating and Reducing Anxiety and Pain in the Paediatric Emergency Department: The TRAPPED survey.

Authors:  Evelyne D Trottier; Samina Ali; Sylvie Le May; Jocelyn Gravel
Journal:  Paediatr Child Health       Date:  2015 Jun-Jul       Impact factor: 2.253

3.  Oxycodone overdose in the pediatric population: case files of the University of Massachusetts Medical Toxicology Fellowship.

Authors:  Katherine L Boyle; Christopher D Rosenbaum
Journal:  J Med Toxicol       Date:  2014-09

4.  Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

Authors:  Naveen Poonai; Gina Bhullar; Kangrui Lin; Adam Papini; David Mainprize; Jocelyn Howard; John Teefy; Michelle Bale; Cindy Langford; Rodrick Lim; Larry Stitt; Michael J Rieder; Samina Ali
Journal:  CMAJ       Date:  2014-10-27       Impact factor: 8.262

5.  Codeine use among children in the United States: a nationally representative study from 1996 to 2013.

Authors:  Margaret J Livingstone; Cornelius B Groenewald; Jennifer A Rabbitts; Tonya M Palermo
Journal:  Paediatr Anaesth       Date:  2016-10-25       Impact factor: 2.556

6.  Knowledge, attitudes and practices of Canadian pediatric emergency physicians regarding short-term opioid use: a descriptive, cross-sectional survey.

Authors:  Megan Fowler; Samina Ali; Serge Gouin; Amy L Drendel; Naveen Poonai; Maryna Yaskina; Mithra Sivakumar; Esther Jun; Kathryn Dong
Journal:  CMAJ Open       Date:  2020-03-16

7.  Pain management in children: Part 2 - A transition from codeine to morphine for moderate to severe pain in children.

Authors:  Cecile Wong; Elaine Lau; Lori Palozzi; Fiona Campbell
Journal:  Can Pharm J (Ott)       Date:  2012-11

8.  Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse Events.

Authors:  Cecilia P Chung; S Todd Callahan; William O Cooper; William D Dupont; Katherine T Murray; Andrew D Franklin; Kathi Hall; Judith A Dudley; C Michael Stein; Wayne A Ray
Journal:  Pediatrics       Date:  2018-07-16       Impact factor: 7.124

9.  A Model of the Intersection of Pain and Opioid Misuse in Children and Adolescents.

Authors:  Genevieve F Dash; Anna C Wilson; Benjamin J Morasco; Sarah W Feldstein Ewing
Journal:  Clin Psychol Sci       Date:  2018-06-05

Review 10.  Paracetamol: a focus for the general pediatrician.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Egidio Barbi
Journal:  Eur J Pediatr       Date:  2013-12-28       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.